Antimicrobial Agents and Chemotherapy, July 2000, p. 1878-1886, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
-Lactamases in Chryseobacterium
meningosepticum
Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre Cedex, France
Received 4 October 1999/Returned for modification 14 February 2000/Accepted 21 April 2000
Although the carbapenem-hydrolyzing
-lactamase (CH
L) BlaB-1
is known to be in Chryseobacterium meningosepticum NCTC
10585, a second CH
L gene, blaGOB-1, was
cloned from another C. meningosepticum clinical isolate
(PINT). The G+C content of blaGOB-1 (36%)
indicated the likely chromosomal origin of this gene. Its expression in Escherichia coli DH10B yields a mature CH
L with a pI of
8.7 and a relative molecular mass of 28.2 kDa. In E. coli,
GOB-1 conferred resistance to narrow-spectrum cephalosporins and
reduced susceptibility to ureidopenicillins, broad-spectrum
cephalosporins, and carbapenems. GOB-1 had a broad-spectrum hydrolysis
profile including penicillins and cephalosporins (but not aztreonam).
The catalytic efficiency for meropenem was higher than for imipenem.
GOB-1 had low amino acid identity with the class B CH
Ls, sharing
18% with the closest, L-1 from Stenotrophomonas
maltophilia, and only 11% with BlaB-1. Most of the conserved
amino acids that may be involved in the active site of CH
Ls
(His-101, Asp-103, His-162, and His-225) were identified in GOB-1.
Sequence heterogeneity was found for GOB-1-like and BlaB-1-like
-lactamases, having 90 to 100% and 86 to 100% amino acid identity,
respectively, among 10 unrelated C. meningosepticum
isolates. Each isolate had a GOB-1-like and a BlaB-1-like gene. The
same combination of GOB-1-like and BlaB-1-like
-lactamases was not
found in two different isolates. C. meningosepticum is a
bacterial species with two types of unrelated chromosome-borne class B
CH
Ls that can be expressed in E. coli and, thus, may represent a clinical threat if spread in gram-negative aerobes.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |